QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,337 signal articles · 533 in last 24h · 104,455 total before filter · latest 25m ago
533last 24h
2513last 7d
481● bullish (7d)
256● bearish (7d)
198publishers
AllMacro203Earnings1518M&A141Regulatory17Product7Analyst29
✕ clear all filtersticker: ^GSPCsentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
Pepsi Earnings Beat Expectations. Why the Stock Is Dropping.
Barrons.com27d agoneutral
Pepsi Earnings Beat Expectations. Why the Stock Is Dropping.

PepsiCo stock was falling Thursday after the soft drinks and snacks maker said it had lost market share in North America, overshadowing a second-quarter earnings beat. The maker of Lay’s, Doritos, Pepsi, and Gatorade reported an adjusted profit of $2.20 a share for the second quarter, as revenue climbed 6.4% from a year ago to $24.18 billion. Analysts were expecting adjusted earnings of $2.19 a share on revenue of $23.95 billion, according to a FactSet poll.

Inflation Fears Retake the Stage
The Wall Street Journal28d agoneutral
Inflation Fears Retake the Stage

Markets tumbled after President Trump said the ceasefire with Iran may be over. Speaking in Turkey at the NATO summit, the president said the U.S. was likely to continue strikes. The Nasdaq Composite, however, managed a 0.2% gain.

OFG Bancorp (OFG): Buy, Sell, or Hold Post Q1 Earnings?
StockStory28d agoneutral
OFG Bancorp (OFG): Buy, Sell, or Hold Post Q1 Earnings?

Since July 2021, the S&P 500 has delivered a total return of 74.3%. But one standout stock has nearly doubled the market - over the past five years, OFG Bancorp has surged 140% to $49.88 per share. Its momentum hasn’t stopped as it’s also gained 19.7% in the last six months thanks to its solid quarterly results, beating the S&P by 10.8%.

HCA Healthcare (HCA): Buy, Sell, or Hold Post Q1 Earnings?
StockStory28d agoneutral
HCA Healthcare (HCA): Buy, Sell, or Hold Post Q1 Earnings?

Over the past six months, HCA Healthcare’s stock price fell to $423.55. Shareholders have lost 11.6% of their capital, which is disappointing considering the S&P 500 has climbed by 9%. This might have investors contemplating their next move.

Ameresco (AMRC): Buy, Sell, or Hold Post Q1 Earnings?
StockStory28d agoneutral
Ameresco (AMRC): Buy, Sell, or Hold Post Q1 Earnings?

Over the last six months, Ameresco’s shares have sunk to $25.63, producing a disappointing 12.5% loss - a stark contrast to the S&P 500’s 9% gain. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.

Trump Accounts Just Went Live. Here’s Why You Must Open One Today
24/7 Wall St.28d agoneutral
Trump Accounts Just Went Live. Here’s Why You Must Open One Today

For generations, the stock market has quietly done something no savings account has ever been able to match — it has turned patience into wealth. Despite recessions, wars, inflation, and market crashes, the S&P 500 has delivered roughly a 10% average annual return over the long run. That simple fact has helped millions of Americans ... Trump Accounts Just Went Live. Here’s Why You Must Open One Today

Investing.com28d agoneutral
BofA says S&P 500 technicals point to corrective Q3

Investing.com -- Bank of America told investors in a note on Wednesday that its third-quarter bias for the S&P 500 remains corrective, outlining a bull/bear debate that will likely be resolved by price action in July.

Samsung Highlights Risk For Tech Stocks: Lofty Earnings Expectations
Investor's Business Daily29d agoneutral
Samsung Highlights Risk For Tech Stocks: Lofty Earnings Expectations

S&P 500 companies are expected to report 23.3% earnings growth for Q2, the second straight quarter above 20% and far above the average growth rate of 16.4% over the past five years, according to FactSet. The key question for markets, according to famed investment strategist Ed Yardeni, is whether analysts got carried away after Q1 earnings and set the bar too high. "The big risk up ahead is that technology companies, especially the hyperscalers, won't beat analysts' overly optimistic earnings growth estimates for the quarter," Yardeni wrote in Monday note.

Renasant (RNST): Buy, Sell, or Hold Post Q1 Earnings?
StockStory29d agoneutral
Renasant (RNST): Buy, Sell, or Hold Post Q1 Earnings?

Renasant has had an impressive run over the past six months as its shares have beaten the S&P 500 by 13%. The stock now trades at $42.99, marking a 21% gain. This run-up might have investors contemplating their next move.